Ann: Cancer Vaccine Study Results, page-106

Why? The results have been demanded ( scheduled Dec2018) I agree with you the vaccine side is BIOTECH.

Do you think the proven BARD1-Ovarian cancer blood test  (see 16/6/2018 announcement and others), BARD1-Breast cancer blood test (see 23/10/2018 announcement) and the Lung Cancer blood test are the same as a Vaccine or Drug development?

The blood test Assay Development program with the development partner Thermo Fisher Scientific (A minnow with about US$100billion market cap) The Assay Development program shortly, "expected completion in 1H19"  (See QTRly 25 Jan 2019) ) to allow the final step"Laboratory Developed Tests (LDTs) in 2021" (See QTRly 25 Jan 2019)

The further work on the vaccines is and was all pre Phase 1,2 and 3 ( That is BIOTECH and very expensive and long time frame) BD 1 cost on the current work has been very very low most unlike a BIOTECH


Well funded, in talks for partners to distributed, market or more for the world first blood tests for ovarian, breast and lung cancers. Seems most unlike a BIOTECH  to me. I saw the negative reaction to the BIOTECH side as a great opportunity myself. ( yes I did )
Not many if any Biotechs with expected completion in 1H19 and possible sales of blood test in 2021.